These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21373701)

  • 21. Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.
    Domchek SM; Postel-Vinay S; Im SA; Park YH; Delord JP; Italiano A; Alexandre J; You B; Bastian S; Krebs MG; Wang D; Waqar SN; Lanasa M; Rhee J; Gao H; Rocher-Ros V; Jones EV; Gulati S; Coenen-Stass A; Kozarewa I; Lai Z; Angell HK; Opincar L; Herbolsheimer P; Kaufman B
    Lancet Oncol; 2020 Sep; 21(9):1155-1164. PubMed ID: 32771088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
    Clément-Zhao A; Tanguy ML; Cottu P; De La Lande B; Bontemps P; Lemanski C; Baumann P; Savignoni A; Levy C; Peignaux K; Reynaud-Bougnoux A; Gobillion A; Kirova Y
    PLoS One; 2019; 14(8):e0221816. PubMed ID: 31469859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
    Morrison SA; Hill SL; Rogers GS; Graham RA
    J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free DOX and chitosan-N-arginine conjugate stabilized indocyanine green nanoparticles for combined chemophotothermal therapy.
    Jheng PR; Lu KY; Yu SH; Mi FL
    Colloids Surf B Biointerfaces; 2015 Dec; 136():402-12. PubMed ID: 26440756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors.
    Luo L; Zhu C; Yin H; Jiang M; Zhang J; Qin B; Luo Z; Yuan X; Yang J; Li W; Du Y; You J
    ACS Nano; 2018 Aug; 12(8):7647-7662. PubMed ID: 30020768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial.
    von Minckwitz G; Colleoni M; Kolberg HC; Morales S; Santi P; Tomasevic Z; Zhang N; Hanes V
    Lancet Oncol; 2018 Jul; 19(7):987-998. PubMed ID: 29880292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Krop IE; Mayer IA; Ganju V; Dickler M; Johnston S; Morales S; Yardley DA; Melichar B; Forero-Torres A; Lee SC; de Boer R; Petrakova K; Vallentin S; Perez EA; Piccart M; Ellis M; Winer E; Gendreau S; Derynck M; Lackner M; Levy G; Qiu J; He J; Schmid P
    Lancet Oncol; 2016 Jun; 17(6):811-821. PubMed ID: 27155741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
    Nozaki M; Kagami Y; Machida R; Nakamura K; Ito Y; Nishimura Y; Teshima T; Saito Y; Nagata Y; Matsumoto Y; Akimoto T; Hiraoka M;
    Jpn J Clin Oncol; 2021 May; 51(6):865-872. PubMed ID: 33728450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results.
    Perez EA; López-Vega JM; Petit T; Zamagni C; Easton V; Kamber J; Restuccia E; Andersson M
    Breast Cancer Res; 2016 Dec; 18(1):126. PubMed ID: 27955684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
    Borges VF; Ferrario C; Aucoin N; Falkson C; Khan Q; Krop I; Welch S; Conlin A; Chaves J; Bedard PL; Chamberlain M; Gray T; Vo A; Hamilton E
    JAMA Oncol; 2018 Sep; 4(9):1214-1220. PubMed ID: 29955792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?].
    Turpin A; Mailliez A; Vennin P; Bonneterre J
    Gynecol Obstet Fertil; 2014 May; 42(5):325-30. PubMed ID: 24411340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
    Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Cufer T; Lobelle JP; Mattiaci MR; Piccart M; Paridaens R
    Ann Oncol; 2004 Feb; 15(2):211-7. PubMed ID: 14760111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of metastatic screening in early primary breast cancer.
    Barry MC; Thornton F; Murphy M; Younis F; Watson RG
    Ir J Med Sci; 1999; 168(4):248-50. PubMed ID: 10624363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An imagable and photothermal "Abraxane-like" nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors.
    Chen Q; Liang C; Wang C; Liu Z
    Adv Mater; 2015 Feb; 27(5):903-10. PubMed ID: 25504416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study.
    Chen WR; Adams RL; Higgins AK; Bartels KE; Nordquist RE
    Cancer Lett; 1996 Jan; 98(2):169-73. PubMed ID: 8556705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
    Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
    BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy.
    Reichardt P; Von Minckwitz G; Thuss-Patience PC; Jonat W; Kölbl H; Jänicke F; Kieback DG; Kuhn W; Schindler AE; Mohrmann S; Kaufmann M; Lück HJ
    Ann Oncol; 2003 Aug; 14(8):1227-33. PubMed ID: 12881384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.
    Shigekawa T; Osaki A; Sekine H; Sato N; Kanbayashi C; Sano H; Takeuchi H; Ueda S; Nakamiya N; Sugitani I; Sugiyama M; Shimada H; Hirokawa E; Takahashi T; Saeki T
    BMC Cancer; 2015 Apr; 15():253. PubMed ID: 25884795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.